+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-10-24Number of Pages: 170

In Vitro Diagnostics Quality Control Market (Product Type - Whole Blood Based Controls, Serum/Plasma Based Controls, Urine Based Controls, Data Management Solutions, Quality Assurance Services; Application - Immunochemistry, Clinical Chemistry, Hematology, Molecular Diagnostics, Microbiology; End Use - Hospitals, Clinical Laboratories, Research and Academic Institutes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022

Global In Vitro Diagnostics (IVD) Quality Control Market: Snapshot

The increasing prominence of the in vitro diagnostics sector in healthcare and its growing use across a number of regions across the world has boosted demand from the global in vitro diagnostics quality control market. In vitro diagnostics quality controls have taken on a crucial role in modern healthcare due to the better accuracy of diagnoses offered by their use and are thus likely to remain in demand in the coming years. The global in vitro diagnostics quality control market is thus likely to exhibit a steady CAGR of 3.3% over the 2017-2022 forecast period.

Transparency Market Research estimates the global in vitro diagnostics quality control market to rise to a valuation of US$710.8 mn by the end of 2017 and further rise to US$837 mn by the end of 2022. The steady rise in investment in the healthcare sector in recent years from governments as well as leading private sector players is likely to aid smooth growth of the in vitro diagnostics quality control market in the coming years.

global in vitro diagnostics quality control market

Whole Blood Based Controls Set to Dominate Global In Vitro Diagnostics Quality Control Market

The report segments the global in vitro diagnostics quality control market by product type into whole blood based controls, serum/plasma based controls, urine based controls, data management solutions, quality assurance services, and others. Of these, whole blood based controls are likely to dominate the global in vitro diagnostics quality control market in the coming years due to the comprehensive assessment they provide in in vitro diagnostics. The whole blood based controls segment of the global in vitro diagnostics quality control market is expected to be valued at US$208.5 mn by the end of 2017 and further rise to US$238.5 mn by the end of 2022. The segment’s 2.7% CAGR over the 2017-2022 forecast period is likely to lead to its share in the market dropping from 29.3% to 28.5% by 2022, but its annual growth figure of US$6 mn is the highest in the global in vitro diagnostics quality control market.

North America to Remain Most Promising Region for In Vitro Diagnostics Quality Control Market

The North America market for in vitro diagnostics quality controls is expected to rise from US$262.8 mn in 2017 to US$311.7 mn by the end of 2022. North America accounted for close to 37% of the global in vitro diagnostics quality control market in 2017 and is likely to remain similarly dominant in the global figures over the 2017-2022 forecast period. The North America in vitro diagnostics quality control market is likely to exhibit a strong 3.5% CAGR between 2017 and 2022 to remain the most attractive region for in vitro diagnostics quality control market players.

APEJ to Match North America’s CAGR, to Rise to US$136 mn by 2022

Despite North America’s dominance in the in vitro diagnostics quality control market, Asia Pacific except Japan is also likely to play a prominent role in the development of the global in vitro diagnostics quality control market in the coming years. The Asia Pacific except Japan in vitro diagnostics quality control market is expected to exhibit a strong 3.5% CAGR over the 2017-2022 forecast period, rising to a valuation of US$136 mn by the end of 2022.

In Vitro Diagnostics (IVD) Quality Control Market: Competitive Dynamics

Key players in the global in vitro diagnostics quality control market include Abbott Laboratories, Bio-Rad Laboratories Inc., Helena Laboratories, Ortho Clinical Diagnostics Inc., Randox Laboratories Ltd., Roche Diagnostics, Seracare Life Sciences Inc., Siemens Healthineers, Sun Diagnostics LLC, Thermo Fisher Scientific Inc., Sysmex Corporation, and Quantimetrix Corporation.

Global In Vitro Diagnostics (IVD) Quality Control Market: Overview

The global in vitro diagnostics quality control market report provides a complete overview of the global market, covering the growth trajectory exhibited by the market in recent years and the key factors responsible for it, the current position of the in vitro diagnostics quality control market with respect to the various factors that affect its growth, and the likely growth prospects of various components of the global in vitro diagnostics quality control market over the 2017-2022 forecast period. The report analyzes the 2012-2017 growth figures of the global in vitro diagnostics quality control market in order to provide readers with a clear picture of the market’s historical growth trajectory and the major factors responsible for its growth prospects. A detailed factbank describing the global in vitro diagnostics quality control market’s 2016 position is provided in the report, illuminating readers on the current position of several components of the market.

According to Transparency Market Research, the global in vitro diagnostics quality control market is likely to be valued at US$710.8 mn by the end of 2017 and further rise to US$837 mn by the end of 2022. The in vitro diagnostics quality control market is likely to exhibit a steady 3.3% CAGR over the 2017-2022 forecast period.

Global In Vitro Diagnostics (IVD) Quality Control Market: Dynamics

The key drivers and restraints affecting the global in vitro diagnostics quality control market are assessed in detail in the report in order to provide readers with a clear picture of how they are affecting the market. The qualitative as well as quantitative impact of the key drivers is assessed in the report to this end. The report also includes a detailed summary of the in vitro diagnostics quality control market’s most important restraints, which can help acquaint readers with the factors likely to disturb their operations in the in vitro diagnostics quality control market in the coming years.

Global In Vitro Diagnostics (IVD) Quality Control Market: Segmentation

The segmentation of the global in vitro diagnostics quality control market is described in detail in the report in order to familiarize readers with the granular structure of the market. The historical performance of the segments of the in vitro diagnostics quality control market from 2012 to 2017 is assessed in the report to provide pointers as to the likely growth trajectory of the components between 2017 and 2022. Description of the past and present hierarchy of the in vitro diagnostics quality control market thus helps readers assess the trends likely to dominate the market’s growth trajectory in the coming years.

The report segments the global in vitro diagnostics quality control market by product type into whole blood based controls, serum/plasma based controls, urine based controls, data management solutions, quality assurance services, and others. By end use, the global in vitro diagnostics quality control market is segmented into hospitals, clinical laboratories, research and academic institutes, and others. Key applications of the in vitro diagnostics quality control market studied in the report include immunochemistry, clinical chemistry, hematology, molecular diagnostics, microbiology, and others. To understand the geographical hierarchy of the global in vitro diagnostics quality control market, the report studies the market’s performance in North America, Latin America, Europe, the Middle East and Africa, Japan, and Asia Pacific except Japan.

Global In Vitro Diagnostics (IVD) Quality Control Market: Competitive Dynamics

The competitive environment in the global in vitro diagnostics quality control market is studied in the report to provide conclusions regarding the major factors shaping the competitive dynamics in the market. Leading players in the in vitro diagnostics quality control market are profiled in the report to obtain actionable insight into strategies that have enabled sustained success in the market. Key players in the global in vitro diagnostics quality control market include Abbott Laboratories, Bio-Rad Laboratories Inc., Helena Laboratories, Ortho Clinical Diagnostics Inc., Randox Laboratories Ltd., Roche Diagnostics, Seracare Life Sciences Inc., Siemens Healthineers, Sun Diagnostics LLC, Thermo Fisher Scientific Inc., Sysmex Corporation, and Quantimetrix Corporation.


 
 
Back To Top